These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19933994)

  • 1. Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome.
    Palomba S; Falbo A; Giallauria F; Russo T; Tolino A; Zullo F; Colao A; Orio F
    Diabetes Care; 2010 Feb; 33(2):246-51. PubMed ID: 19933994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate supplementation fails to affect vascular function and carotid artery intima media thickness in cyclosporin A-treated renal transplant recipients.
    Austen SK; Fassett RG; Geraghty DP; Coombes JS
    Clin Nephrol; 2006 Nov; 66(5):373-9. PubMed ID: 17140167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study.
    Orio F; Palomba S; Cascella T; De Simone B; Manguso F; Savastano S; Russo T; Tolino A; Zullo F; Lombardi G; Azziz R; Colao A
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6072-6. PubMed ID: 16118336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.
    Carlsen SM; Kjøtrød S; Vanky E; Romundstad P
    Acta Obstet Gynecol Scand; 2007; 86(2):145-50. PubMed ID: 17364275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial.
    Kilicdag EB; Bagis T; Tarim E; Aslan E; Erkanli S; Simsek E; Haydardedeoglu B; Kuscu E
    Hum Reprod; 2005 Jun; 20(6):1521-8. PubMed ID: 15790610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin.
    Fruzzetti F; Ghiadoni L; Virdis A; De Negri F; Perini D; Bucci F; Giannarelli C; Gadducci A; Taddei S
    J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):489-495. PubMed ID: 27018756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.
    Potter K; Hankey GJ; Green DJ; Eikelboom J; Jamrozik K; Arnolda LF
    BMC Cardiovasc Disord; 2008 Sep; 8():24. PubMed ID: 18803866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
    Kilicdag EB; Bagis T; Zeyneloglu HB; Tarim E; Aslan E; Haydardedeoglu B; Erkanli S
    Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin administration improves endothelial function in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E; Alexandraki K; Protogerou A; Piperi C; Papamichael C; Aessopos A; Lekakis J; Mavrikakis M
    Eur J Endocrinol; 2005 May; 152(5):749-56. PubMed ID: 15879361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.
    Arikan S; Akay H; Bahceci M; Tuzcu A; Gokalp D
    Fertil Steril; 2009 Feb; 91(2):450-5. PubMed ID: 18501898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
    Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome.
    Orio F; Palomba S; Cascella T; De Simone B; Di Biase S; Russo T; Labella D; Zullo F; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4588-93. PubMed ID: 15356067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment.
    Aarsand AK; Carlsen SM
    J Intern Med; 1998 Aug; 244(2):169-74. PubMed ID: 10095804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
    Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
    Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus.
    Sahin M; Tutuncu NB; Ertugrul D; Tanaci N; Guvener ND
    J Diabetes Complications; 2007; 21(2):118-23. PubMed ID: 17331860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.
    Mancini F; Cianciosi A; Reggiani GM; Facchinetti F; Battaglia C; de Aloysio D
    Fertil Steril; 2009 Jun; 91(6):2537-44. PubMed ID: 18462732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.
    Kaya C; Pabuccu R; Berker B; Satiroglu H
    Fertil Steril; 2010 Mar; 93(4):1200-7. PubMed ID: 19131059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.